US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz ...

The programme includes the ECLIPSE 1 and ECLIPSE 2 Phase III trials, aiming to offer registrational data for regulatory ...

Speaking in an interview on the sideline of the launch of the programme in Birnin Kebbi on Saturday, Dr Suwaiba Jadadi from ...

Nigeria striker Taiwo Awoniyi is currently preparing for life after football by enrolling in a Sporting Directorship course ...

Merit Medical has enrolled the first patient in the PREEMIE study of the Bloom Micro Occluder System, aimed at treating PDA.

Swedish biotechnology company Hansa Biopharma has finished enrolling subjects in a Phase III trial in Europe evaluating ...

Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcers SOLASCURE Ltd (SolasCure), a biotechnology ...

As part of its activities to reduce maternal mortality, a non-governmental organisation, the Clinton Health Access Initiative ...

The Kebbi Government has enrolled 100 women with disabilities into the State Contributory Health Management Agency. Speaking in an interview on the sideline of the launch of the programme in ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2.

Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcers SOLASCURE Ltd (SolasCure), a biotechnology ...